Host: Bruce Japsen <br>

  Guest: Lawrence Cohen, PhD <br>


  
    <p>For more than 150 years, medical researchers have known that atherosclerosis had an inflammatory component. But Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals tells host Bruce Japsen of the Chicago Tribune why there has not been anything done about it.</p>

Host: Bruce Japsen Guest: Lawrence Cohen, PhD For more than 150 years, medical researchers have known that atherosclerosis had an inflammatory component. But Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals tells host Bruce Japsen of the Chicago Tribune why there has not been anything done about it.

After More Than 150 Years, Recent Progress in Atherosclerosis Treatment

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Share After More Than 150 Years, Recent Progress in Atherosclerosis Treatment

Sign up to save your podcasts

After More Than 150 Years, Recent Progress in Atherosclerosis Treatment

After More Than 150 Years, Recent Progress in Atherosclerosis Treatment

More shows like Clinician's Roundtable

The Peter Attia Drive

Huberman Lab